Low/Intermediate PCa Video Chat, 4/27/2026

Low/Intermediate PCa Video Chat, 4/27/2026

by | May 10, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, 4/27/2026

Low/Intermediate PCa Video Chat, 4/27/2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Treatment at Center of Excellence (COE) preferred over Community Care. (bj)

Topics Discussed
Using the Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram to predict the success rate of surgery versus recurrence risk; clinical significance of cribriform patterns in pathology reports; Androgen Deprivation Theory (ADT) & Cardiac Health means understanding the diffference between short- and long-term risks as well as the importance of cardio-oncology monitoring; getting second opinions from on pathology reports are important to confirm Gleason score and identify other potential concerns; treatment at a Center of Execellence (COE) preferred over Community Care because COE offer integrated, multi-disciplianary and access to advanced technologies.

Chat

AnCan – Boykin sent a chat · 8:01 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Boykin sent a chat · 8:02 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Steve Ft Worth sent a chat · 8:15 PM
STeven Warwick

AnCan – Rick sent a chat · 8:19 PM
GoTo  877 582 7011    for tech assistance

AnCan Bill sent a chat · 8:31 PM
http://nomograms.mskcc.org/Prostate/index.aspx

AnCan – Boykin sent a chat · 8:38 PM
Have him run the MSKCC nomogram http://nomograms.mskcc.org/Prostate/index.aspx

David in Portland, OR sent a chat · 8:39 PM
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial (Sushentsev, Nikita): https://jamanetwork.com/journals/jamaoncology/article-abstract/2840006?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamaoncol.2025.4125

Jp sent a chat · 8:46 PM
Can I ask a question on here by chat ?

Jp sent a chat · 8:47 PM
Ok

AnCan Bill sent a chat · 8:49 PM
JP – you can put something in the chat. If you wait until the end, we’ll get to you in the virtual room.

Jp sent a chat · 8:50 PM
Thank you

My question is about the real side effects of chemo

My doctor wants me to start in September

Jp sent a chat · 8:52 PM
Got it thank you

Jp sent a chat · 8:52 PM
New

Jp sent a chat · 8:53 PM
🙏

AnCan – Rick sent a chat · 9:07 PM
Focal therapy article on our bloghttps://ancan.org/prostate-cancer-focal-therapy-as-primary-treatment/

AnCan – Rick sent a chat · 9:08 PM
https://ancan.org/prostate-cancer-focal-therapy-as-primary-treatment/

David in Portland, OR sent a chat · 9:55 PM
A Phase III Randomize Controlled Trial of Sterotactic Body Radiotherapy in Localized Prostate Cancer: Pace-B Trial (van As, Nicholas): https://pmc.ncbi.nlm.nih.gov/articles/PMC7616714/?utm_source=chatgpt.com

AnCan Bill sent a chat · 9:58 PM
https://ancan.org/events/month/

Predicting Radiation Side Effects – PROSTOX Webinar with interesting updates!

Predicting Radiation Side Effects – PROSTOX Webinar with interesting updates!

by | Apr 29, 2026 | High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Prostate Cancer, Webinars

Predicting Radiation Side Effects – PROSTOX Webinar with interesting updates!

 

 

Last year, we presented a webinar on predicting Prostate Cancer Radiation Treatment side effects with PROSTOX before treatment begins. By analyzing your unique genetics, you can make smarter, more informed decisions to avoid side effects and safeguard your quality of life for years to come.

PROSTOX Standard (previously PROSTOX CFRT+) predicts late grade ≥2 toxicity from conventionally fractionated (CFRT) or moderately hypofractionated (MHFRT) radiation therapy for patients with localized prostate cancer. Together with PROSTOX Ultra, which is already available for patients considering stereotactic body radiation therapy (SBRT), the PROSTOX portfolio now provides risk assessment across a broader range of external beam radiation therapy (EBRT) types. We’ll discuss the updates and other patient concerns, such as insurance coverage and questions to bring to your doctors.

To find a copy of the slides, click here.

Low/Intermediate PCa Video Chat, 4/27/2026

Low/Intermediate PCa Video Chat, 4/13/2026

by | Apr 15, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, 4/13/2026

Low/Intermediate PCa Video Chat, 4/13/2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Questions about the efficacy of clinical trials for focal therapy treatment of prostate cancer. (bj)

Topics Discussed
New diagnosis and seeking second opinions on treatment options; potential candidate for active surveillance; importance of getting second opinion on biopsy results; Stereotactic Body Radiation Therapy (SBRT) scheduled—5 sessions over a 10-day period; concerns about traveling to a center of excellence for treatment and then receiving follow-up care locally; questions about the efficacy of clinical trails in general and specifically focal therapy for prostate cancer; difficulties in getting insurance companies to approve medical treatments; differences between germline and somatic (Decipher) genetic testing; avoid the “Google Trap”—don’t make your treatment decisions based on internet searches.

Chat

AnCan – Stuart sent a chat · 7:54 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 7:55 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan – Rick sent a chat · 8:19 PM
The Emperor… Great scans and a PSA of 0.2 with a healthy prostate 😏

David in Portland, OR sent a chat · 8:52 PM
“Delayed Definitive Management of Localized Prostate Cancer: What Do We Know?” Co-authors include Peter Carroll and Mack Roach, https://doi.org/10.1038/s41391-024-00876-2

AnCan – Rick sent a chat · 8:59 PM
PROMISE https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

AnCan – Boykin sent a chat · 9:00 PM
AnCan Foundation YouTube Channel
https://www.youtube.com/@ancanfoundation

medium.com/@mperloe sent a chat · 9:02 PM
Thanks guys. Hope all is well.

AnCan – Boykin sent a chat · 9:03 PM
All is well. Good to see you.

Steve in Malaysia sent a chat · 9:08 PM
I have a few short questions.

AnCan – Rick sent a chat · 9:09 PM
Have to wait until the back end, Steve

Steve in Malaysia sent a chat · 9:09 PM
ok 👍

AnCan – Boykin sent a chat · 9:15 PM
AnCan Prostox https://ancan.org/?s=prostox

Bill (VA) sent a chat · 9:26 PM
https://clinicaltrials.gov/study/NCT06807359

David in Portland, ORsent a chat · 9:46 PM
“Can You Take Cash From Medicare Patients?” https://elitenp.com/medicare-and-cash-practices/?utm_source=chatgpt.com

AnCan – Rick sent a chat · 9:49 PM
Thank you David….

Low/Intermediate PCa Video Chat, 4/27/2026

Low/Intermediate PCa Video Chat, March 23, 2026

by | Apr 7, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, March 23, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT). (bj)

Topics Discussed
Importance of getting a second opinion on bioposy results; clincal study comparison of High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT); necessity of getting a second opinion on bioposy results for a Gleason 3+3 diagnosis; efficacy of specific supplements and dietary changes in reducing future prostate cancer risk and managing PSA levels.

Chat

Stuart sent a chat · 7:41 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Stuart sent a chat · 7:42 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Steve in Malaysia sent a chat · 8:49 PM
Hi guys, can you add me? Have a few questions.

Bill Franklin sent a chat · 8:51 PM
We should have plenty of time Steve.

Steve in Malaysia sent a chat · 8:51 PM
Thanks

Bill Franklin sent a chat · 9:08 PM
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:09 PM
I think this is the one you’re talking about?  Just published in JAMA in Feb, 2026.

Bill Franklin sent a chat · 9:10 PM
JAMA HDR vs SBRT study https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:10 PM
Rick and I had the same one.

Albert sent a chat · 9:16 PM
Thanks guys

AnCan – Rick sent a chat · 9:27 PM
https://themarsh.org/soloartsheal   Greg Burns  this Wednesday at 7.30 pm PACIFIC

Terri Richards sent a chat · 9:29 PM
Thank You So much Rick, My mic was not working > Thank you for all that you all do !

Ron Jr sent a chat · 9:30 PM
I forgot to ask:  Should I get a 2nd opinion on my Biopsy diagnosis of my GL 3+3 lesion? (or feel lucky about it, and sit down and be grateful)  Additionally, are there proven supplements or dietary changes that can reduce my future Prostate Cancer risk & PSA test numbers?

PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life

by | Apr 2, 2026 | Active Surveillance PCa, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Prostate Cancer

PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life

 

 

PCPEP – learn how to employ the Science and Practice of an Anti‑Inflammatory Lifestyle – With Dr. Rob Rutledge

AnCan is all about survivorship – improving Quality of Life after diagnosis, with a focus on diet/nutrition, exercise, stress management, and more.

We now welcome PCPEP (Prostate Cancer Patient Empowerment Program), a Canadian-based program at Dalhousie University in Halifax, Nova Scotia. https://pcpep.org to our AnCan family.

PCPEP’s goal is to optimize survivorship for prostate cancer patients and others. It does this through daily emails and videos focused on components that contribute to your QoL – exercise, nutrition, stress reduction, and the social connection that makes AnCan a big family.

Watch Co-founder Dr. Rob Rutledge, a GU radiation oncologist, explain the program.

The program is FREE and currently open to ALL men with a prostate cancer diagnosis. Although the presentation was made to Gents in early Active Surveillance, it is open to all levels.

To find a copy of the slides, click here.

AnCan thanks our Sponsors – Novartis, Blue Earth, Telix, and Foundation Medicine

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

by | Mar 25, 2026 | Advocacy, Blood Cancers, Cancer Caregivers, Cancer Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, MedaFit, Men 'Speaking Freely', Multiple Sclerosis, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Uncategorized, Visual Snow Syndrome, Webinars

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

Can You Hear Us??       How AnCan helps patients make their voice heard – amplifying the patient voice!
Rick Davis gives keynote address at Houston Methodist Neal Cancer Center 12th Annual Cancer Symposium. August 2024.
Click  https://youtu.be/wCQlHIzKoA0-